A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens

International Journal of Antimicrobial Agents

Volumn 32, Issue 2, 2008, Pages 180-185

  Talwar, G P ^a   Dar, Sajad A ^a   Rai, Mahendra K ^a,b   Reddy, K V R ^c   Mitra, Debashis ^d   Kulkarni, Sujata V ^d   Doncel, Gustavo F ^e   Buck, Christopher B ^f   Schiller, John T ^f   Muralidhar, Sumathi ^g   Bala, Manju ^g   Agrawal, S S ^b   Bansal, Kavita ^a   Verma, Jitendra K ^a  

^a Talwar Research Foundation   (India)

^b UNIVERSITY OF DELHI   (India)

^c NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^d NATIONAL CENTRE FOR CELL SCIENCE   (India)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g SAFDARJUNG HOSPITAL   (India)

Author keywords

Basant; Candida; HIV; HPV; Neisseria gonorrhoeae

Indexed keywords

ALOE VERA EXTRACT; AMPHOTERICIN B; CIPROFLOXACIN; CURCUMIN; EMBLICA OFFICINALIS EXTRACT; MICROBICIDE; NALIDIXIC ACID; PENICILLIN G; PYRROLE; SAPONIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 16; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; VAGINA CANDIDIASIS;

ALOE; ANIMALS; ANTI-INFECTIVE AGENTS; CANDIDA; CURCUMIN; FEMALE; GENITAL DISEASES, FEMALE; HELA CELLS; HIV-1; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEISSERIA GONORRHOEAE; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; RABBITS; SAPINDUS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 46249089775     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.03.004     Document Type: Article

References (16)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. http://www.who.int/docstore/hiv/GRSTI/002.htm [accessed 31 March 2008].
2. World Health Organization. Human papillomavirus infection and cervical cancer. http://www.who.int/vaccine_research/diseases/hpv/en [accessed 31 March 2008].
3. Nabhan A. Vulvovaginal candidiasis. Ain Shams J Obstet Gynecol 3 (2006) 73-79
4. Anderson Jr. R.A., Feathergill K., Kirkpatrick R., Zaneveld L.J.D., Coleman K.T., Spear P.G., et al. Characterization of cysteamine as a potential contraceptive anti-HIV agent. J Androl 19 (1998) 37-49
5. Chen S.C.A., O'Donnell M.L., Gordon S., and Gilbert G.L. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique. J Antimicrob Chemother 37 (1996) 265-273
6. Simoes J.A., Citron D.M., Aroutcheva A., Anderson Jr. R.A., Chany II C.J., Waller D.P., et al. Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis. Antimicrob Agents Chemother 46 (2002) 2692-2695
7. Kumar M., and Mitra D. Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication. J Biol Chem 280 (2005) 40041-40050
8. Krebs F.C., Miller S.R., Ferguson M.L., Labib M., Rando R.F., and Wigdahl B. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Pharmacother 59 (2005) 438-445
9. Buck C.B., Thompson C.D., Roberts J.N., Müller M., Lowy D.R., and Schiller J.T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2 (2006) e69
10. Dhondt M.M.M., Adriaens E., Roey J.V., and Remon J.P. The evaluation of the local tolerance of vaginal formulations containing dapivirine using the slug mucosal irritation test and the rabbit vaginal irritation test. Eur J Pharm Biopharm 60 (2005) 419-425
11. Davis R.H., Leitner M.G., Russo J.M., and Byrne M.E. Wound healing. Oral and topical activity of Aloe vera. J Am Podiatr Med Assoc 79 (1989) 559-562
12. Chandra D., and Gupta S. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res 60 (1972) 138-142
13. Jing Z., Yong Z., Yan Z., and Wei C. Anti-tumor effect of curcumin on human cervical carcinoma HeLa cells in vitro and in vivo. Chin J Cancer Res 19 (2007) 32-36
14. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Res 21 (2001) 2895-2900
15. Bhengraj A.R., Dar S.A., Talwar G.P., and Mittal A. Potential of a novel polyherbal formulation Basant for prevention of Chlamydia trachomatis infection. Int J Antimicrob Agents 32 (2008) 84-88
16. Sharma RS, Mathur AK, Chandhiok N, Datey S, Saxena NC, Gopalan S, et al. Phase II clinical trial with Praneem polyherbal tablet for assessment of its efficacy in symptomatic women with abnormal vaginal discharge (An ICMR Task Force Study). Trans R Soc Trop Med Hyg 2008 (in press).